109 related articles for article (PubMed ID: 14993256)
1. Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat.
McMillan DE; Hardwick WC; Li M; Gunnell MG; Carroll FI; Abraham P; Owens SM
J Pharmacol Exp Ther; 2004 Jun; 309(3):1248-55. PubMed ID: 14993256
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
Byrnes-Blake KA; Laurenzana EM; Landes RD; Gentry WB; Owens SM
Eur J Pharmacol; 2005 Oct; 521(1-3):86-94. PubMed ID: 16182279
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
[TBL] [Abstract][Full Text] [Related]
4. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration.
Clemens KJ; Cornish JL; Hunt GE; McGregor IS
Pharmacol Biochem Behav; 2006 Oct; 85(2):454-63. PubMed ID: 17112571
[TBL] [Abstract][Full Text] [Related]
5. Neither non-contingent electric footshock nor administered corticosterone facilitate the acquisition of methamphetamine self-administration.
Moffett MC; Goeders NE
Pharmacol Biochem Behav; 2005 Feb; 80(2):333-9. PubMed ID: 15680186
[TBL] [Abstract][Full Text] [Related]
6. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats.
Pentel PR; Dufek MB; Roiko SA; Lesage MG; Keyler DE
J Pharmacol Exp Ther; 2006 May; 317(2):660-6. PubMed ID: 16407464
[TBL] [Abstract][Full Text] [Related]
8. High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats.
Cornish JL; Clemens KJ; Thompson MR; Callaghan PD; Dawson B; McGregor IS
J Psychopharmacol; 2008 Jan; 22(1):100-10. PubMed ID: 18187537
[TBL] [Abstract][Full Text] [Related]
9. Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.
McDaid J; Tedford CE; Mackie AR; Dallimore JE; Mickiewicz AL; Shen F; Angle JM; Napier TC
Drug Alcohol Depend; 2007 Jan; 86(1):55-66. PubMed ID: 16762517
[TBL] [Abstract][Full Text] [Related]
10. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
[TBL] [Abstract][Full Text] [Related]
11. Differences in extinction responding and reinstatement of methamphetamine-seeking behavior between Fischer 344 and Lewis rats.
Kruzich PJ; Xi J
Pharmacol Biochem Behav; 2006 Mar; 83(3):391-5. PubMed ID: 16574207
[TBL] [Abstract][Full Text] [Related]
12. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.
Laurenzana EM; Byrnes-Blake KA; Milesi-Hallé A; Gentry WB; Williams DK; Owens SM
Drug Metab Dispos; 2003 Nov; 31(11):1320-6. PubMed ID: 14570763
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
Laurenzana EM; Stevens MW; Frank JC; Hambuchen MD; Hendrickson HP; White SJ; Williams DK; Owens SM; Gentry WB
Hum Vaccin Immunother; 2014; 10(9):2638-47. PubMed ID: 25483484
[TBL] [Abstract][Full Text] [Related]
14. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse.
Shepard JD; Bossert JM; Liu SY; Shaham Y
Biol Psychiatry; 2004 Jun; 55(11):1082-9. PubMed ID: 15158427
[TBL] [Abstract][Full Text] [Related]
15. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty].
Gong YB; Lu XH; Ke XY; Zhou J; Yuan W; Tang MF; Luo XY; Cui GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1523-9. PubMed ID: 18819859
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.
Hambuchen MD; Rüedi-Bettschen D; Gunnell MG; Hendrickson H; Owens SM
Hum Vaccin Immunother; 2016 Sep; 12(9):2240-8. PubMed ID: 27163775
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody.
McMillan DE; Hardwick WC; Li M; Owens SM
Behav Pharmacol; 2002 Sep; 13(5-6):465-73. PubMed ID: 12394422
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships.
Keyler DE; Roiko SA; Benlhabib E; LeSage MG; St Peter JV; Stewart S; Fuller S; Le CT; Pentel PR
Drug Metab Dispos; 2005 Jul; 33(7):1056-61. PubMed ID: 15843487
[TBL] [Abstract][Full Text] [Related]
19. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.
Laurenzana EM; Gunnell MG; Gentry WB; Owens SM
J Pharmacol Exp Ther; 2003 Sep; 306(3):1092-8. PubMed ID: 12829731
[TBL] [Abstract][Full Text] [Related]
20. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
